ReviewExpert opinion on pharmacotherapy2021

An evaluation of ledipasvir + sofosbuvir for the treatment of chronic hepatitis C infection.

Pearson Balatow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.